Home > Blog > The influence of mdrs article 117 in the marketing of combination products

The Influence of MDR’s Article 117 in the Marketing of Combination Products

Regulatory Consulting

The European Union Medical Device Regulation’s (MDR) Article 117 brings improved patient safety measures with new implications for manufacturers, as they must fulfill a significant set of additional requirements.

Listen to the full episode on Veristat’s Advancing Revolutionary Therapies Podcast to learn more about the Article and its influence on the marketing of combination products.

Learning Points

  • What are Drug Device Combination (DDC) products
  • What is Article 117 of the MDR
  • The impact of Article 117 on Manufacturers

LISTEN TO PODCAST

 

Meet Veristat. Learn More.

2 min read

2nd Annual Clinical Outsourcing Group CRO Summit

Oct 17, 2025  Veristat Events

Meet Veristat at 2nd Annual Clinical Outsourcing Group CRO Summit December 2-3, 2025

Veristat is proud to participate...

2 min read

Outsourcing in Clinical Trials New England

Oct 2, 2025  Veristat Events

Meet Veristat at Outsourcing in Clinical Trials New England

Veristat is excited to participate in the 17th Annual...